Solitary Papillary Breast Carcinoma Metastasis to the Large Bowel Presenting as Primary colon Carcinoma: Case Report and Review of the Literature

Dhar, Sorabh; Kulaylat, Mahmoud N.; Gordon, Kelly; Lall, Purin; Doerr, Ralph J.
September 2003
American Surgeon;Sep2003, Vol. 69 Issue 9, p799
Academic Journal
Breast carcinoma has the potential for widespread dissemination. Spread to the lower gastrointestinal tract is infrequent, often multifocal, occurs in association with spread to other sites, and most commonly develops from lobular carcinoma. Solitary colorectal metastasis as the first and sole manifestation of spread is a rare occurrence and can be confused with primary intestinal malignancy. We present a case of metastatic papillary breast carcinoma presenting as a perforated primary colon cancer. Identity of the lesion was confirmed by direct histologic comparison of the resected tumor with prior breast specimen, cytokeratin expression, and the presence of estrogen receptors.


Related Articles

  • Breast Cancer Metastasis To The Colon: A Case Report And Review Of The Literature. Kilgore, Todd; Grewal, Ajitinder; Bechtold, Matthew; Miick, Ronald; Diaz-Arias, Alberto; Ibdah, Jamal; Bragg, Jack // Internet Journal of Gastroenterology;2007, Vol. 6 Issue 1, p3 

    Breast cancer is one of the most common malignancies in the United States. Breast cancer frequently metastasizes to the bones, lungs, and liver; however, metastasis to the colon is rare with the presentation often being varied and nonspecific. Early diagnosis and prompt treatment may prolong...

  • MicroRNA-9 up-regulation is involved in colorectal cancer metastasis via promoting cell motility. Zhu, Liang; Chen, Huarong; Zhou, Donger; Li, Dan; Bai, Rui; Zheng, Shu; Ge, Weiting // Medical Oncology;Jun2012, Vol. 29 Issue 2, p1037 

    Human microRNA-9 (miR-9) has been reported to be involved in the metastasis of several malignancies including brain breast cancer. However, its role in the metastasis of colorectal cancer (CRC) remains to be revealed. Here, we evaluated miR-9 expression in metastatic CRC and investigated its...

  • Cancer Metastasis.  // Journal of Cancer Research & Clinical Oncology;2004 Supplement 1, Vol. 130, pS138 

    Presents abstracts of articles about cancer metastasis. Expression of the matrix-metalloproteinases during liver metastasis of colorectal carcinoma; Molecular detection of clinical colorectal cancer metastasis; Gene expression profiling of MDA-MG-231 breast cancer cells.

  • Breast Metastasis from Colonic Primary: A Case Report and Review of the Literature. DEL PRETE, CHRISTOPHER; DEL PRETE, SALVATORE A.; BABKOWSKI, ROBERT C. // Connecticut Medicine;Aug2009, Vol. 73 Issue 7, p399 

    Colorectal cancer most commonly metastasizes to the liver and lung. The development of breast metastases is exceptionally rare and is associated with poor clinical outcomes. We report a case of colonic adenocarcinoma metastatic to the breast and review the literature.

  • Lebermetastasen. Wellner, U. F.; Keck, T.; Brabletz, T. // Der Chirurg;Jun2010, Vol. 81 Issue 6, p551 

    Liver metastases are most often caused by colorectal cancer, followed by pancreatic and breast cancer. Metastasis constitutes the last step of malignant tumor progression. Molecular investigations point towards an important role of the epithelial-mesenchymal transition (EMT) as a mechanism of...

  • An effective 5-fluorouracil, levofolinate, and oxaliplatin therapy for recurrent breast cancer: a case report. Makoto Takahashi; Koichiro Niwa; Shun Ishiyama; Kiichi Sugimoto; Hiromitsu Komiyama; Yukihiro Yaginuma; Yutaka Kojima; Michitoshi Goto; Atsushi Okuzawa; Yuichi Tomiki; Kazuhiro Sakamoto // Journal of Medical Case Reports;2014, Vol. 8 Issue 1, p1 

    Introduction Therapy comprising 5-fluorouracil, levofolinate, and oxaliplatin is currently the most common chemotherapy for colorectal cancer. We experienced a successful case of advanced colon cancer and recurrent breast cancer with 5-fluorouracil, levofolinate, and oxaliplatin therapy. Case...

  • Sodium channel-inhibiting drugs and survival of breast, colon and prostate cancer: a population-based study. Watt, Ian; Martin, Fabiola; Fairhurst, Caroline; Bland, Martin; Brackenbury, William J. // Scientific Reports;11/20/2015, p16758 

    Metastasis is the leading cause of cancer-related deaths. Voltage-gated sodium channels (VGSCs) regulate invasion and metastasis. Several VGSC-inhibiting drugs reduce metastasis in murine cancer models. We aimed to test the hypothesis that patients taking VGSC-inhibiting drugs who developed...

  • Endobronchial Metastases from Colorectal Adenocarcinomas: Clinical and Endoscopic Characteristics and Patient Prognosis. Coriat, Romain; Diaz, Olivia; De la Fouchardiére, Christelle; Desseigne, Françoise; Négrier, Sylvie // Oncology;2007, Vol. 73 Issue 5/6, p395 

    Background: Endobronchial metastases (EBM) secondary to extrapulmonary solid malignant tumours are rare but may occur. The most common extrathoracic malignancies associated with EBM are breast, renal and colorectal carcinomas. This study aimed to evaluate the clinical and bronchoscopic aspects...

  • Paired related homoeobox 1, a new EMT inducer, is involved in metastasis and poor prognosis in colorectal cancer. Takahashi, Y; Sawada, G; Kurashige, J; Uchi, R; Matsumura, T; Ueo, H; Takano, Y; Akiyoshi, S; Eguchi, H; Sudo, T; Sugimachi, K; Doki, Y; Mori, M; Mimori, K // British Journal of Cancer;7/23/2013, Vol. 109 Issue 2, p307 

    Background:Paired related homoeobox 1 (PRRX1) has been identified as a new epithelial-mesenchymal transition (EMT) inducer in breast cancer. However, the function of PRRX1 in colorectal cancer (CRC) has not been elucidated.Methods:We utilised ectopic PRRX1-expressing cell lines to analyse the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics